Internal Medicine, Rheumatology · Glen Mills, PA
NPI
1295909919
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
30 Lacrue Ave Ste 101
Glen Mills, PA, 19342
Phone (610) 558-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$8.4M
965,257 services
Medicare patients, 2024
1,034
Average age 74
Drug cost, 2024
$2.8M
3,806 prescriptions
Company payments, 2025
$2,396
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nehal S Gandhi was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 507,600 times for 158 patients. In total Nehal S Gandhi billed 965,257 services in 38 codes, and Medicare paid $8.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 507,600 | 158 | $3.60 | $1.8M |
| J3262 Injection, tocilizumab, 1 mg | Office | 191,463 | 59 | $4.69 | $897K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 65,668 | 96 | $9.10 | $598K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 64,525 | 109 | $33.82 | $2.2M |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 36,750 | 33 | $8.61 | $316K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 35,890 | 57 | $24.68 | $886K |
| J0897 Injection, denosumab, 1 mg | Office | 24,840 | 256 | $20.57 | $511K |
| J3247 Injection, secukinumab, intravenous, 1 mg | Office | 13,625 | 15 | $13.72 | $187K |
| J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 4,400 | 72 | $5.83 | $26K |
| 96401 Chemotherapy Administration | Office | 3,301 | 411 | $60.55 | $200K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,404 | 233 | $0.77 | $1,856 |
| 96413 Chemotherapy Administration | Office | 2,161 | 316 | $108.33 | $234K |
| 99214 Office E&M - Established | Office | 1,891 | 717 | $105.18 | $199K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,809 | 29 | $0.23 | $419 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,359 | 620 | $13.31 | $18K |
By year: 2022 $8.5M for 833,088 services; 2023 $8.2M for 908,209 services; 2024 $8.4M for 965,257 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nehal S Gandhi prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 591 prescriptions and refills. In total Nehal S Gandhi wrote 3,806 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 591 | 1,315 | 176 | $25K |
| Methotrexate Methotrexate Sodium | 520 | 1,198 | 176 | $16K |
| Prednisone Generic | 453 | 873 | 185 | $4,679 |
| Gabapentin Generic | 319 | 678 | 107 | $5,573 |
| Duloxetine Hcl Generic | 207 | 491 | 70 | $3,588 |
| Alendronate Sodium Generic | 192 | 429 | 70 | $1,499 |
| Sulfasalazine Dr Sulfasalazine | 169 | 377 | 51 | $10K |
| Leflunomide Generic | 143 | 347 | 52 | $8,766 |
| Folic Acid Generic | 96 | 243 | 38 | $1,549 |
| Meloxicam Generic | 92 | 147 | 28 | $263 |
| Methylprednisolone Generic | 77 | 103 | 38 | $1,094 |
| Celecoxib Generic | 73 | 153 | 25 | $2,484 |
| Allopurinol Generic | 66 | 178 | 21 | $770 |
| Humira(Cf) Pen Adalimumab | 56 | 65 | 12 | $715K |
| Sulfasalazine Generic | 52 | 132 | 20 | $1,578 |
Brand drugs: - claims; generic drugs: 3,212 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nehal S Gandhi $2,396 ($2,396 in general payments such as food, travel and fees) from 8 companies. The largest payer was Janssen Biotech, Inc. with $1,900.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.